Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieping Chen

Showing results (61-70 of 304) with videos related to

Pageof 31
Sort By:
Cancer Research|June 18, 2002
Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cellsKenneth F May, Lieping Chen, Pan Zheng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activityRyan A Wilcox, Koji Tamada, Scott E Strome, et al.
Oncoimmunology|December 22, 2018
B7-H1 agonists could prevent disseminated inflammation by desensitizing cell susceptibility to cytotoxic T-cellsWeiwei Yu, Ling Chen, Sizheng Guo, et al.
The Yale Journal of Biology and Medicine|December 20, 2011
Blockade of the B7-H1/PD-1 pathway for cancer immunotherapyDallas B Flies, Britt J Sandler, Mario Sznol, et al.
The Journal of Experimental Medicine|April 17, 2002
Ligand binding sites of inducible costimulator and high avidity mutants with improved functionShengdian Wang, Gefeng Zhu, Koji Tamada, et al.
Gastroenterology|July 16, 2008
B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responsesChristian Wahl, Petra Bochtler, Lieping Chen, et al.
Cancer Science|November 4, 2014
Intermittent chemotherapy can retain the therapeutic potential of anti-CD137 antibody during the late tumor-bearing stateMiki Tongu, Nanae Harashima, Koji Tamada, et al.
Social Science & Medicine (1982)|July 1, 2006
Does decentralisation improve human resource management in the health sector? A case study from ChinaXiaoyun Liu, Tim Martineau, Lieping Chen, et al.
Blood|January 14, 2010
CD137 agonist antibody prevents cancer recurrence: contribution of CD137 on both hematopoietic and nonhematopoietic cellsHidehiko Narazaki, Yuwen Zhu, Liqun Luo, et al.
Plos One|September 12, 2013
CD137 facilitates the resolution of acute DSS-induced colonic inflammation in miceJulia M Martínez Gómez, Lieping Chen, Herbert Schwarz, et al.
Pageof 31

Showing results (61-70 of 304) with videos related to

Sort By:
Pageof 31
Cancer Research|June 18, 2002
Anti-4-1BB monoclonal antibody enhances rejection of large tumor burden by promoting survival but not clonal expansion of tumor-specific CD8+ T cellsKenneth F May, Lieping Chen, Pan Zheng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activityRyan A Wilcox, Koji Tamada, Scott E Strome, et al.
Oncoimmunology|December 22, 2018
B7-H1 agonists could prevent disseminated inflammation by desensitizing cell susceptibility to cytotoxic T-cellsWeiwei Yu, Ling Chen, Sizheng Guo, et al.
The Yale Journal of Biology and Medicine|December 20, 2011
Blockade of the B7-H1/PD-1 pathway for cancer immunotherapyDallas B Flies, Britt J Sandler, Mario Sznol, et al.
The Journal of Experimental Medicine|April 17, 2002
Ligand binding sites of inducible costimulator and high avidity mutants with improved functionShengdian Wang, Gefeng Zhu, Koji Tamada, et al.
Gastroenterology|July 16, 2008
B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responsesChristian Wahl, Petra Bochtler, Lieping Chen, et al.
Cancer Science|November 4, 2014
Intermittent chemotherapy can retain the therapeutic potential of anti-CD137 antibody during the late tumor-bearing stateMiki Tongu, Nanae Harashima, Koji Tamada, et al.
Social Science & Medicine (1982)|July 1, 2006
Does decentralisation improve human resource management in the health sector? A case study from ChinaXiaoyun Liu, Tim Martineau, Lieping Chen, et al.
Blood|January 14, 2010
CD137 agonist antibody prevents cancer recurrence: contribution of CD137 on both hematopoietic and nonhematopoietic cellsHidehiko Narazaki, Yuwen Zhu, Liqun Luo, et al.
Plos One|September 12, 2013
CD137 facilitates the resolution of acute DSS-induced colonic inflammation in miceJulia M Martínez Gómez, Lieping Chen, Herbert Schwarz, et al.
Pageof 31